Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis
| Autor: | McCune Wj, Vallance Dk, Lynch Jp rd |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Immunosuppressive treatment
medicine.medical_specialty Clinical Trials as Topic Scleroderma Systemic Cyclophosphamide business.industry Progressive systemic sclerosis Scleroderma lung disease medicine.disease Dermatology Autoimmune Diseases Rheumatology medicine Special section Humans business Lung Diseases Interstitial Immunosuppressive Agents medicine.drug Autoantibodies |
| Zdroj: | Current opinion in rheumatology. 7(3) |
| ISSN: | 1040-8711 |
| Popis: | In this article, we review recent studies on the use of immunosuppressive agents in autoimmune diseases, especially cyclophosphamide. In addition, we begin with a special section on the treatment of scleroderma lung disease, including controversies regarding the indications for immunosuppressive therapy. Scleroderma lung disease is justifiably regarded as one of the "frontiers of medicine" because of its gravity, its often rapidly progressive nature, and the urgency with which improved therapy is needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|